Jill Butterfield

569 total citations
14 papers, 432 citations indexed

About

Jill Butterfield is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Jill Butterfield has authored 14 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Jill Butterfield's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pneumonia and Respiratory Infections (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jill Butterfield is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Pneumonia and Respiratory Infections (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jill Butterfield collaborates with scholars based in United States, Singapore and United Kingdom. Jill Butterfield's co-authors include Thomas P. Lodise, George L. Drusano, Manjunath P. Pai, Nimish Patel, T G Rosano, William Hope, Andrea Lay‐Hoon Kwa, Tim Felton, Ben M. Lomaestro and Keith A. Rodvold and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Infection Control and Hospital Epidemiology.

In The Last Decade

Jill Butterfield

14 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Butterfield United States 13 262 163 156 120 90 14 432
Jufang Wu China 14 241 0.9× 153 0.9× 155 1.0× 163 1.4× 54 0.6× 39 466
Ariadna Padullés Spain 11 213 0.8× 227 1.4× 84 0.5× 174 1.4× 63 0.7× 49 560
Helmi Sulaiman Malaysia 8 216 0.8× 185 1.1× 90 0.6× 115 1.0× 52 0.6× 32 493
Prachi K. Dandekar United States 7 291 1.1× 180 1.1× 99 0.6× 213 1.8× 76 0.8× 11 395
Csaba Fehér Spain 14 157 0.6× 190 1.2× 119 0.8× 180 1.5× 96 1.1× 23 482
Angela Loo United States 10 170 0.6× 151 0.9× 141 0.9× 151 1.3× 55 0.6× 19 446
Abel Jasovich Argentina 10 226 0.9× 211 1.3× 76 0.5× 202 1.7× 71 0.8× 22 439
W. Cliff Rutter United States 11 255 1.0× 126 0.8× 144 0.9× 90 0.8× 33 0.4× 24 402
C A Knupp United States 13 308 1.2× 150 0.9× 128 0.8× 213 1.8× 45 0.5× 19 527
Ana Maria Sandri Brazil 10 340 1.3× 259 1.6× 119 0.8× 410 3.4× 64 0.7× 11 613

Countries citing papers authored by Jill Butterfield

Since Specialization
Citations

This map shows the geographic impact of Jill Butterfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Butterfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Butterfield more than expected).

Fields of papers citing papers by Jill Butterfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Butterfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Butterfield. The network helps show where Jill Butterfield may publish in the future.

Co-authorship network of co-authors of Jill Butterfield

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Butterfield. A scholar is included among the top collaborators of Jill Butterfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Butterfield. Jill Butterfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Butterfield, Jill, et al.. (2014). Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?. Diagnostic Microbiology and Infectious Disease. 80(4). 239–259. 29 indexed citations
2.
3.
Butterfield, Jill, Thomas P. Lodise, Scott Beegle, et al.. (2013). Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations. Journal of Antimicrobial Chemotherapy. 69(1). 176–179. 21 indexed citations
4.
Butterfield, Jill, Thomas P. Lodise, Scott Beegle, et al.. (2013). Pharmacokinetics and Pharmacodynamics of Once-Daily Administration of Intravenous Tobramycin in Adult Patients with Cystic Fibrosis Hospitalized for an Acute Pulmonary Exacerbation. Antimicrobial Agents and Chemotherapy. 57(10). 5175–5177. 9 indexed citations
5.
Felton, Tim, William Hope, Ben M. Lomaestro, et al.. (2012). Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections. Antimicrobial Agents and Chemotherapy. 56(8). 4087–4094. 73 indexed citations
6.
Butterfield, Jill, Bruce A. Mueller, Nimish Patel, et al.. (2012). Daptomycin Pharmacokinetics and Pharmacodynamics in a Pooled Sample of Patients Receiving Thrice-Weekly Hemodialysis. Antimicrobial Agents and Chemotherapy. 57(2). 864–872. 16 indexed citations
7.
Stevens, Vanessa, Thomas P. Lodise, Brian T. Tsuji, et al.. (2012). The Utility of Acute Physiology and Chronic Health Evaluation II Scores for Prediction of Mortality among Intensive Care Unit (ICU) and Non-ICU Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia. Infection Control and Hospital Epidemiology. 33(6). 558–564. 24 indexed citations
8.
Lodise, Thomas P., Jill Butterfield, Sharath S. Hegde, Emil Samara, & Steven L. Barriere. (2012). Telavancin Pharmacokinetics and Pharmacodynamics in Patients with Complicated Skin and Skin Structure Infections and Various Degrees of Renal Function. Antimicrobial Agents and Chemotherapy. 56(4). 2062–2066. 22 indexed citations
9.
Butterfield, Jill, Kenneth Lawrence, Arlene Reisman, et al.. (2011). Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data. Journal of Antimicrobial Chemotherapy. 67(2). 494–502. 30 indexed citations
10.
Butterfield, Jill, Brian T. Tsuji, Jack Brown, et al.. (2011). Predictors of agr Dysfunction in Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates among Patients with MRSA Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 55(12). 5433–5437. 31 indexed citations
11.
Lodise, Thomas P., et al.. (2011). Penetration of Vancomycin into Epithelial Lining Fluid in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 55(12). 5507–5511. 50 indexed citations
12.
Lodise, Thomas P. & Jill Butterfield. (2011). Use of pharmacodynamic principles to inform β‐lactam dosing: “S” does not always mean success. Journal of Hospital Medicine. 6(S1). S16–23. 21 indexed citations
13.
Butterfield, Jill, Nimish Patel, Manjunath P. Pai, et al.. (2011). Refining Vancomycin Protein Binding Estimates: Identification of Clinical Factors That Influence Protein Binding. Antimicrobial Agents and Chemotherapy. 55(9). 4277–4282. 70 indexed citations
14.
Butterfield, Jill. (2009). Using grounded theory and action research to raise attainment in, and enjoyment of, reading. Educational Psychology in Practice. 25(4). 315–326. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jufang Wu Breakdown of academic impact, for papers by Ariadna Padullés Breakdown of academic impact, for papers by Helmi Sulaiman Breakdown of academic impact, for papers by Prachi K. Dandekar Breakdown of academic impact, for papers by Csaba Fehér Breakdown of academic impact, for papers by Angela Loo Breakdown of academic impact, for papers by Abel Jasovich Breakdown of academic impact, for papers by W. Cliff Rutter Breakdown of academic impact, for papers by C A Knupp Breakdown of academic impact, for papers by Ana Maria Sandri
Rankless by CCL
2026